Acute chest syndrome

A complication of sickle cell disease

Acute chest syndrome (ACS) is a serious complication of sickle cell disease (SCD) characterized by chest pain, fever, and pulmonary infiltrates on a chest X-ray. It is a leading cause of morbidity and mortality in patients with sickle cell disease.

Pathophysiology

Acute chest syndrome is primarily caused by the sickling of red blood cells in the pulmonary vasculature, leading to vaso-occlusion and subsequent ischemia and infarction of lung tissue. This process can be triggered by various factors, including infection, fat embolism, and pulmonary embolism. The resulting inflammation and hypoxia further exacerbate the sickling process, creating a vicious cycle.

Clinical Presentation

Patients with acute chest syndrome typically present with sudden onset of chest pain, dyspnea, and fever. Other symptoms may include cough, tachypnea, and hypoxemia. The condition can rapidly progress to acute respiratory distress syndrome (ARDS) if not promptly treated.

Diagnosis

The diagnosis of acute chest syndrome is primarily clinical, supported by imaging and laboratory findings. A chest X-ray typically shows new pulmonary infiltrates, which may be bilateral or unilateral. Laboratory tests often reveal leukocytosis, anemia, and elevated inflammatory markers. Pulse oximetry may show decreased oxygen saturation.

Management

The management of acute chest syndrome involves supportive care and specific treatments to address the underlying causes. Key components of management include:

• Oxygen therapy to maintain adequate oxygenation.
• Intravenous fluids to prevent dehydration and reduce sickling.
• Pain management with analgesics to control chest pain.
• Antibiotics if an infectious cause is suspected.
• Blood transfusion to reduce the proportion of sickled cells and improve oxygen delivery.
• Bronchodilators and incentive spirometry to improve lung function.

Prognosis

The prognosis of acute chest syndrome varies depending on the severity of the episode and the timeliness of treatment. Early recognition and aggressive management are crucial to prevent complications such as respiratory failure and multi-organ failure. Recurrent episodes of acute chest syndrome can lead to chronic lung disease and decreased life expectancy in patients with sickle cell disease.

Prevention

Preventive strategies for acute chest syndrome include regular vaccination against pneumococcus and influenza, hydroxyurea therapy to reduce sickling episodes, and chronic transfusion therapy in high-risk patients. Patient education on recognizing early symptoms and seeking prompt medical attention is also essential.

Related pages

• Sickle cell disease
• Vaso-occlusive crisis
• Pulmonary embolism
• Acute respiratory distress syndrome